Chao Jiang*, Xueyan Liu†, Meng Wang*, Guoyue Lv*, Guangyi Wang*
Oncology Research, Vol.27, No.9, pp. 1025-1034, 2019, DOI:10.3727/096504018X15456687424096
Abstract miR-802 has been reported to be dysregulated in multiple tumors and contribute to tumor progression. However,
its role in HCC was still largely unknown. The aim of this study is to investigate the function and mechanism
of miR-802 in HCC progression. The results showed that miR-802 was upregulated in the peripheral blood
and tumor tissue of HCC patients, and high levels of blood miR-802 predicted poor prognosis. miR-802 had
no effect on the proliferation and migration of HCC cell lines. Interestingly, the levels of CD8/CD28 and
regulated in development and DNA damage response 1 (REDD1) More >